section name header

Basics ⬇

DESCRIPTION

EPIDEMIOLOGY

Prevalence

Prevalence depends on level of sickness of population and location where assessment is performed.

RISK FACTORS

ETIOLOGY

MAT usually occurs during critical illness, especially in the setting of chronic lung disease. #x03B2-Agonists and methylxanthine derivatives (theophylline) may be contributory.

COMMONLY ASSOCIATED CONDITIONS

See above regarding Etiology.

Diagnosis ⬆ ⬇

Signs and symptoms:

DIAGNOSTIC TESTS & INTERPRETATION

DIFFERENTIAL DIAGNOSIS

Medication (Drugs) ⬆ ⬇

First Line

Electrical cardioversion is NOT helpful.

Treatment ⬆ ⬇

ADDITIONAL TREATMENT

General Measures

IN-PATIENT CONSIDERATIONS

Admission Criteria

Usually arrhythmia is 1st recognized in inpatients. Discharge is determined by resolution of other medical problems.

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

PROGNOSIS

Depends on underlying disease

Miscellaneous ⬆ ⬇

CODES

ICD9

427.89 Other, specified cardiac dysrhythmias

SNOMED

49982000 multifocal atrial tachycardia (disorder)

Reference(s) ⬆ ⬇

ADDITIONAL READING

SEE ALSO

Author(s) ⬆

Peter Ott

Andrew E. Epstein